NCT05527184: First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers |
|
|
| Recruiting | 1 | 227 | US | IMGN151 | ImmunoGen, Inc. | Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer | 12/24 | 12/25 | | |